June 21 (UPI) --The U.S. Food and Drug Administration on Friday cleared four NJOY menthol-flavored e-cigarette products to be marketed in the United States. The FDA in a statement said it issued ...
Altria bought NJOY and plugged the company's vaping product into its distribution network. NJOY is enjoying a huge boost in sales, leading to enthusiasm among investors. There are good things ...
The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...
On our last coverage of Altria (NYSE:MO), we pointed out why the results were poor despite the headlines suggesting otherwise. The numbers required you to be cautious and that was our mantra du jour.
Altria Group, Inc.'s (NYSE:MO) proposed $2.75B acquisition of e-vapor company NJOY Holdings has drawn criticism from the investing community and analysts. In late February, Bernstein cautioned that ...
Altria Group Inc. MO said Thursday it expects 2023 adjusted profit of $4.89 to $5.03 a share, compared to the FactSet analyst projection of $5.05 a share. Altria said it has closed its NJoy ...
April 29 (Reuters) - Tobacco company Altria (MO.N), opens new tab on Tuesday beat first-quarter profit estimates but flagged an $873 million impairment at its e-cigarette business, where shipments ...
Altria Group (NYSE:MO) shares are trading higher on Thursday. The company reported third-quarter adjusted earnings per share of $1.38, beating the street view of $1.35. Quarterly sales of $5.334 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback